Log In Get Started

Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

7,850 total articles

YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026
Apr 20, 2026
Ajmal Hussain
Press Releases

YY Group Reports Unaudited Second Half and Full Year 2025 Earnings Results Highlighting Accelerating Revenue Growth, Expanding Margins and Positioning for Profitability in 2026

YY Group Holding Limited announced robust unaudited financial results for full year 2025, with a 39.3% increase in revenue to $57.2 million and a 50.2% rise in gross profit, driven by growth in manpower and integrated facilities management (IFM) segments. The company undertook strategic investments, acquisitions, and geographic expansion across Asi…

YYGH
Safe Pro Reports on Share Repurchase Program, Reinforcing Commitment to Shareholder Value and Capital Return
Apr 20, 2026
Avery Klein
Press Releases

Safe Pro Reports on Share Repurchase Program, Reinforcing Commitment to Shareholder Value and Capital Return

Safe Pro Group Inc. is actively executing a $3 million authorized share repurchase program, having repurchased 400,000 shares to date. Funded by strong cash flow and a solid balance sheet with no debt, the buyback underscores management's confidence in the company's intrinsic value, AI-enabled defense solutions growth, and long-term outlook. The pr…

SPAI
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
Apr 20, 2026
Ajmal Hussain
Press Releases

Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer

Helus Pharma, a clinical-stage pharmaceutical company developing novel serotonergic agonists for mental health conditions, announced the immediate resignation of CEO Michael Cola. Co-founder and Executive Chairman Eric So will resume his role as interim CEO while a search for a permanent replacement is underway. The company continues to focus on ad…

HELP
Genius Group Receives ICC Arbitration Award, Wins Return of 7.4 Million Shares and $8.0 Million Cash Payment
Apr 20, 2026
Derek Hwang
Press Releases

Genius Group Receives ICC Arbitration Award, Wins Return of 7.4 Million Shares and $8.0 Million Cash Payment

Genius Group Limited (NYSE American: GNS), an AI-powered education company, announced it has won a final ICC arbitration award against LZG International, entitling it to the return of approximately 7.4 million shares of its common stock and a cash payment of nearly $8 million. The company is pursuing enforcement and further legal actions related to…

GNS
ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network
Apr 20, 2026
Caleb Monroe
Press Releases

ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network

ZJK Industrial Co., Ltd., a NASDAQ-listed high-tech precision parts manufacturer, announced advancement of its localization strategy through its Vietnamese subsidiary, ZJK Vietnam Precision Components Co. The new facility focuses on R&D and production of precision components for sectors like AI infrastructure, electronics, and automotive, aiming to…

ZJK
Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure
Apr 20, 2026
Nina Shah
Press Releases

Callan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure

Callan JMB Inc. announced the development of Atlas Complex, a 150-acre pharmaceutical, medical, and logistics campus in Marion, Alabama. The facility will support pharmaceutical onshoring, early-stage production, QA/QC, cold-chain logistics, and domestic distribution. Partnering with Monarch Property Management and Walker's Pharmaceuticals of India…

CJMB
Fusion Fuel Highlights Announced Exploration Plan at Jaguar Uranium’s Huemul Project, Potential Royalty Portfolio Income
Apr 20, 2026
Derek Hwang
Press Releases

Fusion Fuel Highlights Announced Exploration Plan at Jaguar Uranium’s Huemul Project, Potential Royalty Portfolio Income

Fusion Fuel Green PLC announced its planned acquisition of a controlling interest in Royal Uranium Inc., which holds a 1.0% NSR royalty on the Huemul Project in Argentina. This strategic move provides Fusion Fuel capital-efficient exposure to uranium, copper, and vanadium resources at a historically significant mining district. Jaguar Uranium's exp…

HTOO
MainStreet Bancshares, Inc. Announces First Quarter 2026 Results
Apr 20, 2026
Nina Shah
Press Releases

MainStreet Bancshares, Inc. Announces First Quarter 2026 Results

MainStreet Bancshares, Inc. reported a net income of $4.1 million for Q1 2026, with EPS of $0.48, driven by a 9 basis point expansion in net interest margin to 3.47%. The company executed a buyback of over 273,000 shares, strengthened its capital position, increased net loans to $1.85 billion, and maintained a strong 98% loan-to-deposit ratio. Depo…

MNSB
Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve
Apr 20, 2026
Caleb Monroe
Press Releases

Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve

Axe Compute Inc., a NASDAQ-listed AI infrastructure platform, announced the launch of its Strategic Compute Reserve (SCR) Dashboard. The dashboard consolidates detailed, real-time insights into the company's GPU asset reserves and stock metrics, improving transparency by integrating the equity valuation with the value and unlock schedule of its AI …

AGPU
Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
Apr 20, 2026
Avery Klein
Press Releases

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Calidi Biotherapeutics presented new compelling data demonstrating the effectiveness of its RedTail virotherapy platform, which systemically delivers targeted genetic medicines for cancer treatment. The company highlighted its lead candidate CLD-401 and introduced CLD-501 targeting TROP2, aiming to improve T-cell engagers' efficacy in solid tumors …

CLDI
Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
Apr 20, 2026
Nina Shah
Press Releases

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Kyverna Therapeutics reported positive longer-term follow-up data from the Phase 2 portion of its KYSA-6 trial evaluating mivocabtagene autoleucel (miv-cel), a CAR T therapy, in patients with generalized myasthenia gravis (gMG). The data demonstrate rapid, robust, and sustained clinical improvements through 52 weeks after a single dose, with all pa…

KYTX
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
Apr 20, 2026
Nina Shah
Press Releases

BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

BioCardia announced a favorable outcome from its clinical consultation with Japan's PMDA for CardiAMP Cell Therapy, signaling likely sufficiency of its clinical data to support regulatory approval for ischemic heart failure treatment in Japan. The company is positioned to become the first to offer a minimally invasive biologic therapy for this cond…

BCDA
Cycurion CEO Kevin Kelly Discusses Operational Execution, Multi‑Year Contract Momentum, and 2026 Growth Priorities in Recent Interview
Apr 20, 2026
Ajmal Hussain
Press Releases

Cycurion CEO Kevin Kelly Discusses Operational Execution, Multi‑Year Contract Momentum, and 2026 Growth Priorities in Recent Interview

Cycurion, Inc. CEO Kevin Kelly discusses the company's strategic transition towards profitable growth through improved operational execution, cost-saving initiatives, and multi-year contract wins, including a significant government partnership. The company aims to grow revenues substantially in the coming years, overcoming prior challenges related …

CYCU
Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile
Apr 20, 2026
Caleb Monroe
Press Releases

Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile

Artelo Biosciences announces publication of peer-reviewed research demonstrating the analgesic potential of its FABP5 inhibitor ART26.12 across multiple pain models, highlighting a differentiated mechanism with a favorable safety profile from Phase 1 studies. The company plans to initiate multiple ascending dose trials later this year to advance cl…

ARTL
RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue
Apr 20, 2026
Leila Farooq
Press Releases

RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue

RedCloud Holdings plc is progressing its RAID AI engine from research to live integration within Turkey's leading distribution network, marking a major step towards commercial deployment. This move follows joint ventures in Turkey and Saudi Arabia, collectively valued up to $80 million, reflecting expansion in high-growth FMCG markets amid global s…

RCT
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
Apr 20, 2026
Nina Shah
Press Releases

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

NewcelX Ltd. announced an updated corporate presentation emphasizing its strategic collaboration with Eledon Pharmaceuticals to develop a combined cell therapy and immune-protection approach targeting Type 1 Diabetes. The company's flagship program, NCEL-101, integrates stem-cell-derived islet replacement with Eledon's immune-modulation antibody te…

NCEL
Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System
Apr 20, 2026
Hana Yamamoto
Press Releases

Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System

Nexera Technologies Ltd announced that its wholly-owned subsidiary, KeepZone AI Inc., has entered a white label agreement to develop and commercialize an advanced AI-powered real-time voice communication decision support system. This platform aims to enhance operational capabilities in managing multiple voice and radio communication channels simult…

NEXR
Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122%
Apr 20, 2026
Maya Rios
Press Releases

Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122%

Swvl Holdings Corp announced fiscal year 2025 financial results showing a 41% increase in revenue to $24.2 million and a net income of $1.3 million, marking a return to profitability after a $10.3 million loss in 2024. Revenue growth was driven by significant expansion in the Gulf Cooperation Council (GCC) region, with GCC revenues up 122%, alongsi…

SWVL